Literature DB >> 24810152

Invasive fungal infections in solid organ transplant recipients.

J Gavaldà1, Y Meije, J Fortún, E Roilides, F Saliba, O Lortholary, P Muñoz, P Grossi, M Cuenca-Estrella.   

Abstract

Solid organ transplant (SOT) recipients have a significant risk of invasive fungal diseases (IFD) caused mainly by Candida spp. and Aspergillus spp. Candida spp. is the most frequent agent of IFD in the transplant recipient. The absence of clinical trials and the epidemiological differences in IFD in different transplant programmes mean that there are no definitive recommendations for the diagnosis, treatment and prevention of IFD in SOT, so most of the evidence must be based on clinical experience.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Drug interactions; Transplant infectious disease; invasive aspergillosis; invasive candidiasis; solid organ transplantation

Mesh：

Substances：

Year:  2014        PMID： 24810152     DOI： 10.1111/1469-0691.12660

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  38 in total

Review 1.  Bloodstream infections after solid-organ transplantation.

Authors:  Antonios Kritikos; Oriol Manuel
Journal:  Virulence       Date:  2016-01-14       Impact factor: 5.882

2.  Population Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.

Authors:  Xuemei Wu; Raman Venkataramanan; Ryan M Rivosecchi; Chenxiao Tang; Rachel V Marini; Ryan K Shields; Cornelius J Clancy; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

3.  The 'hole' story of a lung: Answers.

Authors:  Aadil Kakajiwala; Priyanka Fernandes; Bruce R Pawel; Sandra Amaral
Journal:  Pediatr Nephrol       Date:  2016-07-18       Impact factor: 3.714

4.  Candida-streptococcal mucosal biofilms display distinct structural and virulence characteristics depending on growth conditions and hyphal morphotypes.

Authors:  M M Bertolini; H Xu; T Sobue; C J Nobile; A A Del Bel Cury; A Dongari-Bagtzoglou
Journal:  Mol Oral Microbiol       Date:  2015-04-20       Impact factor: 3.563

5.  Contribution of (1,3)-beta-D-glucan to diagnosis of invasive candidiasis after liver transplantation.

Authors:  E Levesque; S El Anbassi; E Sitterle; F Foulet; J C Merle; F Botterel
Journal:  J Clin Microbiol       Date:  2014-12-17       Impact factor: 5.948

Review 6.  Animal Models of Aspergillosis.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Comp Med       Date:  2018-04-02       Impact factor: 0.982

7.  Comparative Evaluation of Disc Diffusion and E-test with Broth Micro-dilution in Susceptibility testing of Amphotericin B, Voriconazole and Caspofungin against Clinical Aspergillus isolates.

Authors:  Prashant Gupta; Vineeta Khare; Deepak Kumar; Abrar Ahmad; Gopa Banerjee; Mastan Singh
Journal:  J Clin Diagn Res       Date:  2015-01-01

8.  Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.

Authors:  Xuemei Wu; Cornelius J Clancy; Ryan M Rivosecchi; Wenchen Zhao; Ryan K Shields; Rachel V Marini; Raman Venkataramanan; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

9.  Evaluation of Fluorescent Capillary Electrophoresis for Rapid Identification of Candida Fungal Infections.

Authors:  Hana Obručová; Radka Tihelková; Iva Kotásková; Filip Růžička; Veronika Holá; Eva Němcová; Tomáš Freiberger
Journal:  J Clin Microbiol       Date:  2016-03-02       Impact factor: 5.948

Review 10.  Epidemiology of fungal infections in China.

Authors:  Min Chen; Yuan Xu; Nan Hong; Yali Yang; Wenzhi Lei; Lin Du; Jingjun Zhao; Xia Lei; Lin Xiong; Langqi Cai; Hui Xu; Weihua Pan; Wanqing Liao
Journal:  Front Med       Date:  2018-01-11       Impact factor: 4.592
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.